{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:35:43Z","timestamp":1792784143394,"version":"4.5.0"},"reference-count":172,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"NIEHS","doi-asserted-by":"crossref","award":["R37 ES02710"],"award-info":[{"award-number":["R37 ES02710"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH T32","award":["T32 HL86350"],"award-info":[{"award-number":["T32 HL86350"]}]},{"name":"American Asthma Society"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.gene.2013.05.008","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T15:16:17Z","timestamp":1369062977000},"page":"61-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":229,"title":["Soluble epoxide hydrolase: Gene structure, expression and deletion"],"prefix":"10.1016","volume":"526","author":[{"given":"Todd R.","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2013.05.008_bb9000","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1476-5381.2009.00461.x","article-title":"3-methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats","volume":"158","author":"Aboutabl","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0005","doi-asserted-by":"crossref","first-page":"9018","DOI":"10.1073\/pnas.0703229104","article-title":"Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo","volume":"104","author":"Ai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.05.008_bb0010","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.05.008_bb0015","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1124\/dmd.112.046631","article-title":"Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats","volume":"40","author":"Alsaad","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.gene.2013.05.008_bb0020","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/bph.12066","article-title":"Soluble epoxide hydrolase inhibitor, TUPS, protects against isoproterenol-induced cardiac hypertrophy","volume":"168","author":"Althurwi","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0025","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3109\/00498254.2012.693971","article-title":"Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl\/6 mouse heart","volume":"42","author":"Anwar-Mohamed","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.gene.2013.05.008_bb0035","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1073\/pnas.96.19.10637","article-title":"Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase","volume":"96","author":"Argiriadi","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.05.008_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/abbi.1993.1411","article-title":"cDNA cloning and expression of a soluble epoxide hydrolase from human liver","volume":"305","author":"Beetham","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.gene.2013.05.008_bb0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/dna.1995.14.61","article-title":"Gene evolution of epoxide hydrolases and recommended nomenclature","volume":"14","author":"Beetham","year":"1995","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.gene.2013.05.008_bb0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.brainres.2009.07.060","article-title":"Characterization of transgenic mice with neuron-specific expression of soluble epoxide hydrolase","volume":"1291","author":"Bianco","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1744-8069-7-78","article-title":"Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation","volume":"7","author":"Brenneis","year":"2011","journal-title":"Mol. Pain"},{"key":"10.1016\/j.gene.2013.05.008_bb0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3132\/dvdr.2008.021","article-title":"Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study","volume":"5","author":"Burdon","year":"2008","journal-title":"Diab. Vasc. Dis. Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0065","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.taap.2003.08.006","article-title":"Differential metabolism of acrylonitrile to cyanide is responsible for the greater sensitivity of male vs female mice: role of CYP2E1 and epoxide hydrolases","volume":"193","author":"Chanas","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0003-9861(91)90360-U","article-title":"Purification and characterization of an epoxide hydrolase from the peroxisomal fraction of mouse liver","volume":"285","author":"Chang","year":"1991","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.gene.2013.05.008_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2012.08.001","article-title":"Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice","author":"Chaudhary","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.gene.2013.05.008_bb0080","doi-asserted-by":"crossref","first-page":"H1348","DOI":"10.1152\/ajpheart.01326.2007","article-title":"Identification of 15-hydroxy-11,12-epoxyeicosatrienoic acid as a vasoactive 15-lipoxygenase metabolite in rabbit aorta","volume":"294","author":"Chawengsub","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0085","doi-asserted-by":"crossref","first-page":"E563","DOI":"10.1152\/ajpendo.00591.2011","article-title":"Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy","volume":"303","author":"Chen","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.gene.2013.05.008_bb0090","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/HYPERTENSIONAHA.107.102160","article-title":"Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat","volume":"51","author":"Corenblum","year":"2008","journal-title":"Hypertension"},{"issue":"420","key":"10.1016\/j.gene.2013.05.008_bb0095","first-page":"e1","article-title":"Why eicosanoids could represent a new class of tocolytics on uterine activity in pregnant women","volume":"201","author":"Corriveau","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.gene.2013.05.008_bb0100","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1073\/pnas.0437829100","article-title":"The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase","volume":"100","author":"Cronin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.05.008_bb0105","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1476-5381.2010.01113.x","article-title":"The omega-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1\/CDK4 down-regulation","volume":"162","author":"Cui","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0110","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/jpet.105.091876","article-title":"Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition","volume":"316","author":"Davis","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.gene.2013.05.008_bb0115","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/oby.2009.227","article-title":"Expression and regulation of soluble epoxide hydrolase in adipose tissue","volume":"18","author":"De Taeye","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.gene.2013.05.008_bb0120","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1096\/fj.10-171488","article-title":"Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice","volume":"25","author":"Deng","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.gene.2013.05.008_bb0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/toxsci\/50.1.30","article-title":"Soluble epoxide hydrolase in rat inflammatory cells is indistinguishable from soluble epoxide hydrolase in rat liver","volume":"50","author":"Draper","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.gene.2013.05.008_bb0130","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.amjhyper.2005.04.019","article-title":"The prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension","volume":"18","author":"Dreisbach","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.gene.2013.05.008_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/toxsci\/kfh066","article-title":"Epoxide hydrolases in the rat epididymis: possible roles in xenobiotic and endogenous fatty acid metabolism","volume":"78","author":"DuTeaux","year":"2004","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.gene.2013.05.008_bb0140","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1096\/fj.11-188300","article-title":"Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia\u2013reperfusion injury in isolated mouse heart","volume":"25","author":"Edin","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.gene.2013.05.008_bb0145","doi-asserted-by":"crossref","first-page":"R1307","DOI":"10.1152\/ajpregu.00759.2010","article-title":"Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes","volume":"301","author":"Elmarakby","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0160","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/002215540405200403","article-title":"Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues","volume":"52","author":"Enayetallah","year":"2004","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.gene.2013.05.008_bb0150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1369\/jhc.5A6808.2005","article-title":"Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues","volume":"54","author":"Enayetallah","year":"2006","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.gene.2013.05.008_bb0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10735-006-9050-9","article-title":"Distribution of soluble epoxide hydrolase, cytochrome P450 2C8, 2C9 and 2J2 in human malignant neoplasms","volume":"37","author":"Enayetallah","year":"2006","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.gene.2013.05.008_bb0165","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1432-1033.1991.tb16037.x","article-title":"Studies on the intracellular distributions of soluble epoxide hydrolase and of catalase by digitonin-permeabilization of hepatocytes isolated from control and clofibrate-treated mice","volume":"198","author":"Eriksson","year":"1991","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.gene.2013.05.008_bb0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2012.05.048","article-title":"Mechanism of the sex difference in neuronal ischemic cell death","volume":"219","author":"Fairbanks","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.gene.2013.05.008_bb0175","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.HYP.34.6.1242","article-title":"Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells","volume":"34","author":"Fang","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.gene.2013.05.008_bb0180","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/FPC.0b013e3283349ec9","article-title":"Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes","volume":"20","author":"Fava","year":"2010","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.gene.2013.05.008_bb0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1124\/jpet.108.142398","article-title":"Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation","volume":"327","author":"Fife","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.gene.2013.05.008_bb0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.HYP.0000032278.75806.68","article-title":"Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats","volume":"40","author":"Fornage","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.gene.2013.05.008_bb0190","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.CIR.0000109487.46725.02","article-title":"Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: the Coronary Artery Risk Development in Young Adults (CARDIA) study","volume":"109","author":"Fornage","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.gene.2013.05.008_bb0200","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1093\/hmg\/ddi315","article-title":"The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke","volume":"14","author":"Fornage","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.gene.2013.05.008_bb0205","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1073\/pnas.1206493109","article-title":"Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols","volume":"109","author":"Fromel","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.05.008_bb0210","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/HJH.0b013e328345ef7b","article-title":"Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in mice with renovascular hypertension","volume":"29","author":"Gao","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.gene.2013.05.008_bb0215","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0006-291X(79)91872-2","article-title":"Hydration of cis- and trans-epoxymethyl stearates by the cytosolic epoxide hydrase of mouse liver","volume":"89","author":"Gill","year":"1979","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2013.05.008_bb0220","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0006-2952(80)90518-3","article-title":"Distribution and properties of a mammalian soluble epoxide hydrase","volume":"29","author":"Gill","year":"1980","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0225","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1021\/bi036189j","article-title":"Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis","volume":"43","author":"Gomez","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.gene.2013.05.008_bb0235","doi-asserted-by":"crossref","first-page":"17628","DOI":"10.1016\/S0021-9258(19)85378-4","article-title":"Molecular cloning and expression of murine liver soluble epoxide hydrolase","volume":"268","author":"Grant","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2013.05.008_bb0230","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00008571-199404000-00003","article-title":"Chromosomal mapping and expression levels of a mouse soluble epoxide hydrolase gene","volume":"4","author":"Grant","year":"1994","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.gene.2013.05.008_bb0240","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/STROKEAHA.107.502179","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans","volume":"39","author":"Gschwendtner","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.gene.2013.05.008_bb0245","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstrom","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.gene.2013.05.008_bb0255","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0041-008X(83)90342-3","article-title":"Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities","volume":"71","author":"Hammock","year":"1983","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0250","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0305-0491(76)90045-6","article-title":"Soluble mammalian epoxide hydratase: action on juvenile hormone and other terpenoid epoxides","volume":"53","author":"Hammock","year":"1976","journal-title":"Comp. Biochem. Physiol. B"},{"key":"10.1016\/j.gene.2013.05.008_bb0260","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/dna.2008.0751","article-title":"Soluble epoxide hydrolase homologs in Strongylocentrotus purpuratus suggest a gene duplication event and subsequent divergence","volume":"27","author":"Harris","year":"2008","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.gene.2013.05.008_bb0265","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.abb.2008.01.016","article-title":"Identification of two epoxide hydrolases in Caenorhabditis elegans that metabolize mammalian lipid signaling molecules","volume":"472","author":"Harris","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.gene.2013.05.008_bb0270","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1095\/biolreprod.104.035899","article-title":"Identification and characterization of an ovary-selective isoform of epoxide hydrolase","volume":"72","author":"Hennebold","year":"2005","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.gene.2013.05.008_bb9010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/ATVBAHA.108.171298","article-title":"Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice","volume":"29","author":"Hercule","year":"2009","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.gene.2013.05.008_bb0275","first-page":"394","article-title":"Immunocytochemical analysis of soluble epoxide hydrolase and catalase in mouse and rat hepatocytes demonstrates a peroxisomal localization before and after clofibrate treatment","volume":"46","author":"Hollinshead","year":"1988","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.gene.2013.05.008_bb0850","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1113\/jphysiol.2010.199505","article-title":"Renal mechanisms contributing to the antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats with inducible hypertension","volume":"589","author":"Honetschlagerova","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.resuscitation.2007.06.031","article-title":"Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation","volume":"76","author":"Hutchens","year":"2008","journal-title":"Resuscitation"},{"key":"10.1016\/j.gene.2013.05.008_bb0290","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1113\/expphysiol.2006.036889","article-title":"A novel role for P450 eicosanoids in the neurogenic control of cerebral blood flow in the rat","volume":"92","author":"Iliff","year":"2007","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0295","doi-asserted-by":"crossref","first-page":"H1352","DOI":"10.1152\/ajpheart.00950.2008","article-title":"Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels","volume":"296","author":"Iliff","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0300","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.gene.2013.05.008_bb0305","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.gene.2013.05.008_bb0315","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/hy0202.103788","article-title":"Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension","volume":"39","author":"Imig","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.gene.2013.05.008_bb0310","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1258\/ebm.2012.012225","article-title":"Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor gamma agonist improve vascular function and decrease renal injury in hypertensive obese rats","volume":"237","author":"Imig","year":"2012","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.gene.2013.05.008_bb9020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/FJC.0b013e3182580a5d","article-title":"Inhibition of soluble epoxide hydrolase limits niacin-induced vasodilation in mice","volume":"60","author":"Inceoglu","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.gene.2013.05.008_bb0320","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/molehr\/gam044","article-title":"Dynamic expression of epoxyeicosatrienoic acid synthesizing and metabolizing enzymes in the primate corpus luteum","volume":"13","author":"Irusta","year":"2007","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.gene.2013.05.008_bb0325","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mvr.2010.11.003","article-title":"In vivo optical imaging of revascularization after brain trauma in mice","volume":"81","author":"Jia","year":"2011","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0335","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/jpet.107.134858","article-title":"Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells","volume":"326","author":"Jiang","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.gene.2013.05.008_bb0330","doi-asserted-by":"crossref","first-page":"H1990","DOI":"10.1152\/ajpheart.01267.2010","article-title":"Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats","volume":"300","author":"Jiang","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0340","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002040050250","article-title":"Tissue specific basal expression of soluble murine epoxide hydrolase and effects of clofibrate on the mRNA levels in extrahepatic tissues and liver","volume":"70","author":"Johansson","year":"1995","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.gene.2013.05.008_bb0345","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/01.HYP.0000153792.29478.1d","article-title":"Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension","volume":"45","author":"Jung","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.gene.2013.05.008_bb0350","doi-asserted-by":"crossref","first-page":"e11979","DOI":"10.1371\/journal.pone.0011979","article-title":"Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease","volume":"5","author":"Jung","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2013.05.008_bb0355","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0006-2952(86)90275-3","article-title":"Distribution and nature of epoxide hydrolase activity in subcellular organelles of mouse liver","volume":"35","author":"Kaur","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0360","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/cvr\/cvp281","article-title":"Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition","volume":"85","author":"Keseru","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0365","doi-asserted-by":"crossref","first-page":"E691","DOI":"10.1152\/ajpendo.00710.2010","article-title":"Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats","volume":"300","author":"Koeners","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.gene.2013.05.008_bb0370","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1523\/JNEUROSCI.0056-07.2007","article-title":"Polymorphisms in the human soluble epoxide hydrolase gene EPHX2 linked to neuronal survival after ischemic injury","volume":"27","author":"Koerner","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.gene.2013.05.008_bb0375","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.2741\/2889","article-title":"Soluble epoxide hydrolase: regulation by estrogen and role in the inflammatory response to cerebral ischemia","volume":"13","author":"Koerner","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.gene.2013.05.008_bb0380","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000339883","article-title":"Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension","volume":"35","author":"Kopkan","year":"2012","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0385","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2261-9-48","article-title":"Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention","volume":"9","author":"Kullmann","year":"2009","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.gene.2013.05.008_bb0390","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0165-1110(92)90047-D","article-title":"Recombinant DNA approaches for the development of metabolic systems used in in vitro toxicology","volume":"277","author":"Langenbach","year":"1992","journal-title":"Mutat. Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0395","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF00225209","article-title":"Localization of the human soluble epoxide hydrolase gene (EPHX2) to chromosomal region 8p21\u2013p12","volume":"95","author":"Larsson","year":"1995","journal-title":"Hum. Genet."},{"key":"10.1016\/j.gene.2013.05.008_bb0400","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/hmg\/ddl085","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study","volume":"15","author":"Lee","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.gene.2013.05.008_bb0415","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.transproceed.2008.03.137","article-title":"Genetic variations in soluble epoxide hydrolase and graft function in kidney transplantation","volume":"40","author":"Lee","year":"2008","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.gene.2013.05.008_bb0410","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/STROKEAHA.109.567768","article-title":"Genetically reduced soluble epoxide hydrolase activity and risk of stroke and other cardiovascular disease","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.gene.2013.05.008_bb0405","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/HYPERTENSIONAHA.110.161695","article-title":"Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans","volume":"57","author":"Lee","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.gene.2013.05.008_bb0420","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.yjmcc.2009.08.017","article-title":"Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches","volume":"47","author":"Li","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0435","doi-asserted-by":"crossref","first-page":"16747","DOI":"10.1073\/pnas.0508081102","article-title":"The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase","volume":"102","author":"Liu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.05.008_bb0425","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bcp.2009.10.025","article-title":"Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model","volume":"79","author":"Liu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0430","doi-asserted-by":"crossref","first-page":"e39165","DOI":"10.1371\/journal.pone.0039165","article-title":"Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2013.05.008_bb0440","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/jpet.110.167544","article-title":"Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis","volume":"334","author":"Luo","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.gene.2013.05.008_bb0455","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1074\/jbc.M608057200","article-title":"Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice","volume":"282","author":"Luria","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2013.05.008_bb0450","doi-asserted-by":"crossref","first-page":"E375","DOI":"10.1152\/ajpendo.00131.2009","article-title":"Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase","volume":"297","author":"Luria","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.gene.2013.05.008_bb0445","doi-asserted-by":"crossref","first-page":"9038","DOI":"10.1073\/pnas.1103482108","article-title":"Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance","volume":"108","author":"Luria","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.05.008_bb9015","doi-asserted-by":"crossref","first-page":"F740","DOI":"10.1152\/ajprenal.00098.2009","article-title":"Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension","volume":"297","author":"Manhiani","year":"2009","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0460","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1152\/physiolgenomics.00310.2004","article-title":"Tobacco smoke dysregulates endothelial vasoregulatory transcripts in vivo","volume":"21","author":"Maresh","year":"2005","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.gene.2013.05.008_bb0470","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1289\/ehp.10659","article-title":"Tetrahydrofurandiol stimulation of phospholipase A2, lipoxygenase, and cyclooxygenase gene expression and MCF-7 human breast cancer cell proliferation","volume":"115","author":"Markaverich","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.gene.2013.05.008_bb0465","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vph.2011.05.002","article-title":"Estrogens and selective estrogen receptor modulators regulate gene and protein expression in the mesenteric arteries","volume":"55","author":"Mark-Kappeler","year":"2011","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0475","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuroscience.2009.06.033","article-title":"Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism","volume":"163","author":"Marowsky","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.gene.2013.05.008_bb0480","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11010-011-1132-7","article-title":"Regional differences in sexually dimorphic protein expression in the spontaneously hypertensive rat (SHR)","volume":"362","author":"Martin","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.gene.2013.05.008_bb0485","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1017\/S0007114509991450","article-title":"Intervention with fish oil, but not with docosahexaenoic acid, results in lower levels of hepatic soluble epoxide hydrolase with time in apoE knockout mice","volume":"103","author":"Mavrommatis","year":"2010","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.gene.2013.05.008_bb0490","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.yjmcc.2011.11.015","article-title":"Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure","volume":"52","author":"Merabet","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0495","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0304-4165(96)00037-2","article-title":"Novel metabolic pathways for linoleic and arachidonic acid metabolism","volume":"1290","author":"Moghaddam","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.gene.2013.05.008_bb0500","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nm0597-562","article-title":"Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase","volume":"3","author":"Moghaddam","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.gene.2013.05.008_bb0505","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"Monti","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2013.05.008_bb0510","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0041-008X(85)90240-6","article-title":"Epoxide metabolism in the liver of mice treated with clofibrate (ethyl-alpha-(p-chlorophenoxyisobutyrate)), a peroxisome proliferator","volume":"78","author":"Moody","year":"1985","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0515","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0b013e31827fe59c","article-title":"Soluble epoxide hydrolase inhibition does not prevent cardiac remodeling and dysfunction following aortic constriction in rats and mice","author":"Morgan","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0520","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1165\/rcmb.2009-0155OC","article-title":"17,18-Epoxyeicosatetraenoic acid targets PPARgamma and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase","volume":"43","author":"Morin","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.gene.2013.05.008_bb0525","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ps.1583","article-title":"Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical","volume":"64","author":"Morisseau","year":"2008","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.gene.2013.05.008_bb0530","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.gene.2013.05.008_bb0535","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1194\/jlr.M006007","article-title":"Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids","volume":"51","author":"Morisseau","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0540","doi-asserted-by":"crossref","first-page":"H2128","DOI":"10.1152\/ajpheart.00428.2008","article-title":"Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia\u2013reperfusion injury in vivo","volume":"295","author":"Motoki","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0545","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11010-009-0220-4","article-title":"Renal expression of arachidonic acid metabolizing enzymes and RhoA\/Rho kinases in fructose insulin resistant hypertensive rats","volume":"333","author":"Mustafa","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.gene.2013.05.008_bb0560","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11010-010-0686-0","article-title":"Salt modulates vascular response through adenosine A(2A) receptor in eNOS-null mice: role of CYP450 epoxygenase and soluble epoxide hydrolase","volume":"350","author":"Nayeem","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.gene.2013.05.008_bb0555","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1152\/ajpregu.00213.2012","article-title":"Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARgamma","volume":"304","author":"Nayeem","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0570","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1210\/en.2004-0710","article-title":"Cytochrome p450-dependent lipid metabolism in preovulatory follicles","volume":"145","author":"Newman","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.gene.2013.05.008_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2004.10.001","article-title":"Epoxide hydrolases: their roles and interactions with lipid metabolism","volume":"44","author":"Newman","year":"2005","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0575","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2133\/dmpk.24.438","article-title":"Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: high glucose suppresses sEH expression","volume":"24","author":"Oguro","year":"2009","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.gene.2013.05.008_bb0580","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbrc.2005.03.171","article-title":"Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients","volume":"331","author":"Ohtoshi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2013.05.008_bb0585","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1124\/jpet.106.103556","article-title":"Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels","volume":"318","author":"Olearczyk","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.gene.2013.05.008_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2012.09.003","article-title":"Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice","author":"Oni-Orisan","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.gene.2013.05.008_bb0595","first-page":"869","article-title":"Styrene oxide metabolism in rhesus monkey liver: enzyme activities in subcellular fractions and in isolated hepatocytes","volume":"226","author":"Pacifici","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.gene.2013.05.008_bb0600","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mrd.21102","article-title":"Aberrant protein expression is associated with decreased developmental potential in porcine cumulus\u2013oocyte complexes","volume":"77","author":"Paczkowski","year":"2010","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.gene.2013.05.008_bb0605","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1440-1681.2011.05492.x","article-title":"Activation of peroxisome proliferator-activated receptor-gamma downregulates soluble epoxide hydrolase in cardiomyocytes","volume":"38","author":"Pang","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0610","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1172\/JCI58128","article-title":"Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice","volume":"122","author":"Panigrahy","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2013.05.008_bb0615","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1124\/mol.64.2.482","article-title":"Polymorphisms in human soluble epoxide hydrolase","volume":"64","author":"Przybyla-Zawislak","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0620","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.gene.2012.09.016","article-title":"Genetic variants in epoxide hydrolases modify the risk of oligozoospermia and asthenospermia in Han-Chinese population","volume":"510","author":"Qin","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.gene.2013.05.008_bb0625","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/HJH.0b013e32831aedfa","article-title":"Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats","volume":"27","author":"Revermann","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.gene.2013.05.008_bb9040","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/ATVBAHA.110.204099","article-title":"Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice","volume":"30","author":"Revermann","year":"2010","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"10.1016\/j.gene.2013.05.008_bb0630","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1196\/annals.1375.019","article-title":"Eicosanoid imbalance in the NOD mouse is related to a dysregulation in soluble epoxide hydrolase and 15-PGDH expression","volume":"1079","author":"Rodriguez","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.gene.2013.05.008_bb0635","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s100380170067","article-title":"Seventy genetic variations in human microsomal and soluble epoxide hydrolase genes (EPHX1 and EPHX2) in the Japanese population","volume":"46","author":"Saito","year":"2001","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.gene.2013.05.008_bb0645","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/bbrc.1996.0596","article-title":"Structural characterization of the human soluble epoxide hydrolase gene (EPHX2)","volume":"221","author":"Sandberg","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.gene.2013.05.008_bb0640","doi-asserted-by":"crossref","first-page":"28873","DOI":"10.1074\/jbc.M001153200","article-title":"Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms","volume":"275","author":"Sandberg","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2013.05.008_bb0650","doi-asserted-by":"crossref","first-page":"C278","DOI":"10.1152\/ajpcell.00386.2011","article-title":"Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor","volume":"303","author":"Sanders","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0655","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1096\/fj.04-3128fje","article-title":"Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive rat","volume":"19","author":"Sellers","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.gene.2013.05.008_bb0660","doi-asserted-by":"crossref","first-page":"L675","DOI":"10.1152\/ajplung.00427.2010","article-title":"Improved bioavailability of epoxyeicosatrienoic acids reduces TP-receptor agonist-induced tension in human bronchi","volume":"301","author":"Senouvo","year":"2011","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0670","doi-asserted-by":"crossref","first-page":"F552","DOI":"10.1152\/ajprenal.00354.2004","article-title":"Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats","volume":"289","author":"Seubert","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0665","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/01.RES.0000237390.92932.37","article-title":"Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function","volume":"99","author":"Seubert","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0675","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1517\/13543776.2010.484804","article-title":"Soluble epoxide hydrolase inhibitors: a patent review","volume":"20","author":"Shen","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.gene.2013.05.008_bb0680","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/jm201468j","article-title":"Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications","volume":"55","author":"Shen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.gene.2013.05.008_bb0685","doi-asserted-by":"crossref","first-page":"40504","DOI":"10.1074\/jbc.M008106200","article-title":"Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation","volume":"275","author":"Sinal","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2013.05.008_bb0690","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/cr2002992","article-title":"Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis","volume":"111","author":"Smith","year":"2011","journal-title":"Chem. Rev."},{"issue":"Suppl.","key":"10.1016\/j.gene.2013.05.008_bb0695","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50","author":"Spector","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0700","doi-asserted-by":"crossref","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","article-title":"Action of epoxyeicosatrienoic acids on cellular function","volume":"292","author":"Spector","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0705","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.abb.2004.05.003","article-title":"Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure","volume":"427","author":"Srivastava","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.gene.2013.05.008_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2012.07.005","article-title":"Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury","author":"Strauss","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.gene.2013.05.008_bb0715","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1369\/jhc.2008.950659","article-title":"Distribution and expression of soluble epoxide hydrolase in human brain","volume":"56","author":"Sura","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.gene.2013.05.008_bb0720","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbagrm.2007.11.005","article-title":"Transcriptional regulation of the human soluble epoxide hydrolase gene EPHX2","volume":"1779","author":"Tanaka","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.gene.2013.05.008_bb0725","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1016\/0006-2952(89)90528-5","article-title":"Effect of diabetes and starvation on the activity of rat liver epoxide hydrolases, glutathione S-transferases and peroxisomal beta-oxidation","volume":"38","author":"Thomas","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0730","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0b013e318298e460","article-title":"Anti-inflammatory effects of omega-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II dependent hypertension","author":"Ulu","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.gene.2013.05.008_bb0735","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-5793(83)80583-3","article-title":"Epoxide hydrolase activity in isolated peroxisomes of mouse liver","volume":"158","author":"Waechter","year":"1983","journal-title":"FEBS Lett."},{"key":"10.1016\/j.gene.2013.05.008_bb0740","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.prostaglandins.2011.08.001","article-title":"Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception","volume":"96","author":"Wagner","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.gene.2013.05.008_bb0745","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/HJH.0b013e328334dfd4","article-title":"Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats","volume":"28","author":"Walkowska","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.gene.2013.05.008_bb0755","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1080\/10286020.2012.723200","article-title":"Protection of salvianolic acid A on rat brain from ischemic damage via soluble epoxide hydrolase inhibition","volume":"14","author":"Wang","year":"2012","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0750","doi-asserted-by":"crossref","first-page":"F168","DOI":"10.1152\/ajprenal.00129.2012","article-title":"Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage","volume":"304","author":"Wang","year":"2013","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0760","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.atherosclerosis.2006.02.021","article-title":"Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking","volume":"190","author":"Wei","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.gene.2013.05.008_bb0765","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.05.008_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2012.03.167","article-title":"A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARgamma to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction","author":"Xu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0780","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids","volume":"87","author":"Yu","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0775","doi-asserted-by":"crossref","first-page":"F720","DOI":"10.1152\/ajprenal.00165.2003","article-title":"Vascular localization of soluble epoxide hydrolase in the human kidney","volume":"286","author":"Yu","year":"2004","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0800","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/FPC.0b013e3282f313e8","article-title":"Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population","volume":"18","author":"Zhang","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.gene.2013.05.008_bb0815","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/STROKEAHA.107.508325","article-title":"Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia","volume":"39","author":"Zhang","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.gene.2013.05.008_bb0805","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/jcbfm.2009.65","article-title":"Role of soluble epoxide hydrolase in the sex-specific vascular response to cerebral ischemia","volume":"29","author":"Zhang","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.gene.2013.05.008_bb0785","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.bbagrm.2010.09.006","article-title":"DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism","volume":"1799","author":"Zhang","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.gene.2013.05.008_bb0790","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCRESAHA.111.259325","article-title":"Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo","volume":"110","author":"Zhang","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.gene.2013.05.008_bb0820","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1007\/s10620-012-2217-1","article-title":"Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(\u2212\/\u2212) mice","volume":"57","author":"Zhang","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.gene.2013.05.008_bb0810","doi-asserted-by":"crossref","DOI":"10.1002\/mc.21918","article-title":"Reduction of inflammatory bowel disease-induced tumor development in IL-10 knockout mice with soluble epoxide hydrolase gene deficiency","author":"Zhang","year":"2013","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.gene.2013.05.008_bb0795","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1073\/pnas.1304321110","article-title":"Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis and tumorigenesis","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.gene.2013.05.008_bb0830","first-page":"1244","article-title":"Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage","volume":"15","author":"Zhao","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.gene.2013.05.008_bb0825","doi-asserted-by":"crossref","first-page":"R188","DOI":"10.1152\/ajpregu.00018.2004","article-title":"Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats","volume":"288","author":"Zhao","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.gene.2013.05.008_bb0835","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1165\/ajrcmb.25.4.4104","article-title":"Leukotoxin-diol: a putative toxic mediator involved in acute respiratory distress syndrome","volume":"25","author":"Zheng","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.gene.2013.05.008_bb0840","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1124\/dmd.108.023077","article-title":"Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats","volume":"36","author":"Zordoky","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.gene.2013.05.008_bb0845","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1124\/dmd.111.039123","article-title":"Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver","volume":"39","author":"Zordoky","year":"2011","journal-title":"Drug Metab. Dispos."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913006173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111913006173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T18:27:58Z","timestamp":1715365678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111913006173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":172,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0378111913006173"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2013.05.008","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble epoxide hydrolase: Gene structure, expression and deletion","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2013.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}